Japanese encephalitis vaccine
Sponsors
Sanofi Pasteur, a Sanofi Company, Novartis Vaccines, Novartis, Singapore General Hospital, Boryung Pharmaceutical Co., Ltd
Conditions
DengueDengue FeverDengue Hemorrhagic FeverEncephalitis, JapaneseHepatitis AJapanese EncephalitisMeningococcal DiseaseMeningococcal Meningitis
Phase 2
The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans
CompletedNCT01943305
Start: 2013-10-31End: 2015-12-31Updated: 2016-04-20
Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
CompletedNCT01943825
Start: 2013-11-05End: 2015-11-25Updated: 2022-03-24
Phase 3
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines
CompletedNCT00735644
Start: 2008-08-31End: 2009-08-31Updated: 2015-04-21
Novartis Vaccine and Diagnostics Carriage Trial
CompletedNCT01214850
Start: 2010-09-30End: 2012-01-31Updated: 2016-04-21
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults
CompletedNCT01466387
Start: 2011-11-30End: 2012-04-30Updated: 2014-03-11